Skip to main content

MoneyWorks4Me

Shilpa Medicare informs about updates

17 Nov 2025 Evaluate
Shilpa Medicare has informed about the launch of NODUCATM for the first time in India to treat metabolic dysfunction associated fatty liver disease (MAFLD).

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1371.20
Cipla 1409.00
Lupin 1990.00
Zydus Lifesciences 1195.00
View more..